@whytee master spinner preying on the low post count member. Classic.
@hack63
some details on odac here:
https://www.fda.gov/advisory-committees/human-drug-advisory-committees/oncologic-drugs-advisory-committee
so you can see that there is no process where odac intervene when they are concerned about data: this is a fiction.
the issue has been the potency assay piece: mesoblast have not convinced FDA that this is sufficient, yet…
I would go to the mesoblast website and find the webcast that was hosted on August 31 2023: Krause explains it here (mesoblast website > investors & media > events and presentations)
Ann: Change in substantial holding, page-154
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.075(5.12%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.37 | $9.337M | 6.672M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 80200 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 28642 | 2 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |